StockData

NextCure, Inc. (NXTC) stock

NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$6.88+0.18 (+2.76%)

Close on Nov 18, 2026Market cap $31.52MP/E –Yield 0.00%

NextCure operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

NextCure's operating income for the twelve months ending Jun 30, 2026 was -$43.90M. For fiscal 2025 it was -$57.62M. The highest annual figure on record is -$23.20M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$57.62M–
FY2024Dec 31, 2024-$59.75M–
FY2023Dec 31, 2023-$67.64M–
FY2022Dec 31, 2022-$75.91M–
FY2021Dec 31, 2021-$70.77M–
FY2020Dec 31, 2020-$41.23M–
FY2019Dec 31, 2019-$37.48M–
FY2018Dec 31, 2018-$23.20M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$15.09M–
Q1 FY2026Mar 31, 2026-$10.11M–
Q4 FY2025Dec 31, 2025-$9.76M–
Q3 FY2025Sep 30, 2025-$8.95M–
Q2 FY2025Jun 30, 2025-$27.29M–
Q1 FY2025Mar 31, 2025-$11.62M–
Q4 FY2024Dec 31, 2024-$12.46M–
Q3 FY2024Sep 30, 2024-$12.50M–
Q2 FY2024Jun 30, 2024-$16.49M–
Q1 FY2024Mar 31, 2024-$18.30M–
Q4 FY2023Dec 31, 2023-$15.79M–
Q3 FY2023Sep 30, 2023-$15.62M–
Q2 FY2023Jun 30, 2023-$19.16M–
Q1 FY2023Mar 31, 2023-$17.07M–
Q4 FY2022Dec 31, 2022-$17.77M–
Q3 FY2022Sep 30, 2022-$19.24M–
Q2 FY2022Jun 30, 2022-$18.13M–
Q1 FY2022Mar 31, 2022-$20.77M–
Q4 FY2021Dec 31, 2021-$17.07M–
Q3 FY2021Sep 30, 2021-$18.51M–
Q2 FY2021Jun 30, 2021-$17.95M–
Q1 FY2021Mar 31, 2021-$17.23M-309.9%
Q4 FY2020Dec 31, 2020-$16.24M–
Q3 FY2020Sep 30, 2020-$17.40M–
Q2 FY2020Jun 30, 2020-$15.80M–
Q1 FY2020Mar 31, 2020$8.21M–
Q4 FY2019Dec 31, 2019-$12.01M–
Q3 FY2019Sep 30, 2019-$9.70M–
Q2 FY2019Jun 30, 2019-$8.96M–
Q1 FY2019Mar 31, 2019-$6.82M–
Q4 FY2018Dec 31, 2018-$7.07M–
Q3 FY2018Sep 30, 2018-$5.82M–
Q2 FY2018Jun 30, 2018-$5.30M–
Q1 FY2018Mar 31, 2018-$5.01M–

More NextCure figures

See a number that looks wrong?